My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 178

    1.

    Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program.

    Lachin JM, Christophi CA, Edelstein SL, Ehrmann DA, Hamman RF, Kahn SE, Knowler WC, Nathan DM; DDK Research Group.

    Diabetes. 2007 Apr;56(4):1153-9.PMID: 17395752 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    [Progress in the prevention of type 2 diabetes]

    Schernthaner G.

    Wien Klin Wochenschr. 2003 Nov 28;115(21-22):745-57. Review. German. PMID: 14743578 [PubMed - indexed for MEDLINE]Related articles

    3.

    Body size and shape changes and the risk of diabetes in the diabetes prevention program.

    Fujimoto WY, Jablonski KA, Bray GA, Kriska A, Barrett-Connor E, Haffner S, Hanson R, Hill JO, Hubbard V, Stamm E, Pi-Sunyer FX; Diabetes Prevention Program Research Group.

    Diabetes. 2007 Jun;56(6):1680-5. Epub 2007 Mar 15.PMID: 17363740 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.

    Klein DJ, Cottingham EM, Sorter M, Barton BA, Morrison JA.

    Am J Psychiatry. 2006 Dec;163(12):2072-9.PMID: 17151157 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Tolerability and efficacy of exenatide and titrated insulin glargine in adult patients with type 2 diabetes previously uncontrolled with metformin or a sulfonylurea: a multinational, randomized, open-label, two-period, crossover noninferiority trial.

    Barnett AH, Burger J, Johns D, Brodows R, Kendall DM, Roberts A, Trautmann ME.

    Clin Ther. 2007 Nov;29(11):2333-48.PMID: 18158075 [PubMed - indexed for MEDLINE]Related articles

    6.

    Adiponectin, change in adiponectin, and progression to diabetes in the Diabetes Prevention Program.

    Mather KJ, Funahashi T, Matsuzawa Y, Edelstein S, Bray GA, Kahn SE, Crandall J, Marcovina S, Goldstein B, Goldberg R; Diabetes Prevention Program.

    Diabetes. 2008 Apr;57(4):980-6. Epub 2008 Jan 11.PMID: 18192541 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program.

    Perreault L, Ma Y, Dagogo-Jack S, Horton E, Marrero D, Crandall J, Barrett-Connor E; Diabetes Prevention Program.

    Diabetes Care. 2008 Jul;31(7):1416-21. Epub 2008 Mar 20.PMID: 18356403 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Relationship of body size and shape to the development of diabetes in the diabetes prevention program.

    [No authors listed]

    Obesity (Silver Spring). 2006 Nov;14(11):2107-17.PMID: 17135629 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions.

    Ratner RE, Christophi CA, Metzger BE, Dabelea D, Bennett PH, Pi-Sunyer X, Fowler S, Kahn SE; Diabetes Prevention Program Research Group.

    J Clin Endocrinol Metab. 2008 Dec;93(12):4774-9. Epub 2008 Sep 30.PMID: 18826999 [PubMed - indexed for MEDLINE]Related articles

    10.

    Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin.

    Kitabchi AE, Temprosa M, Knowler WC, Kahn SE, Fowler SE, Haffner SM, Andres R, Saudek C, Edelstein SL, Arakaki R, Murphy MB, Shamoon H; Diabetes Prevention Program Research Group.

    Diabetes. 2005 Aug;54(8):2404-14.PMID: 16046308 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effects of withdrawal from metformin on the development of diabetes in the diabetes prevention program.

    Diabetes Prevention Program Research Group.

    Diabetes Care. 2003 Apr;26(4):977-80.PMID: 12663559 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program.

    Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF; Diabetes Prevention Program Research Group.

    Diabetes Care. 2009 Sep;32(9):1583-8. Epub 2009 Jul 8.PMID: 19587364 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.

    Robbins DC, Beisswenger PJ, Ceriello A, Goldberg RB, Moses RG, Pagkalos EM, Milicevic Z, Jones CA, Sarwat S, Tan MH.

    Clin Ther. 2007 Nov;29(11):2349-64.PMID: 18158076 [PubMed - indexed for MEDLINE]Related articles

    14.

    The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial.

    Orchard TJ, Temprosa M, Goldberg R, Haffner S, Ratner R, Marcovina S, Fowler S; Diabetes Prevention Program Research Group.

    Ann Intern Med. 2005 Apr 19;142(8):611-9.PMID: 15838067 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Meta-analysis: metformin treatment in persons at risk for diabetes mellitus.

    Salpeter SR, Buckley NS, Kahn JA, Salpeter EE.

    Am J Med. 2008 Feb;121(2):149-157.e2. Review.PMID: 18261504 [PubMed - indexed for MEDLINE]Related articles

    16.

    Alcohol consumption and diabetes risk in the Diabetes Prevention Program.

    Crandall JP, Polsky S, Howard AA, Perreault L, Bray GA, Barrett-Connor E, Brown-Friday J, Whittington T, Foo S, Ma Y, Edelstein SL; Diabetes Prevention Program Research Group.

    Am J Clin Nutr. 2009 Sep;90(3):595-601. Epub 2009 Jul 29.PMID: 19640960 [PubMed - indexed for MEDLINE]Related articles

    17.

    Effect of metformin on patients with impaired glucose tolerance.

    Li CL, Pan CY, Lu JM, Zhu Y, Wang JH, Deng XX, Xia FC, Wang HZ, Wang HY.

    Diabet Med. 1999 Jun;16(6):477-81.PMID: 10391395 [PubMed - indexed for MEDLINE]Related articles

    18.

    Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.

    Harden KA, Cowan PA, Velasquez-Mieyer P, Patton SB.

    J Am Acad Nurse Pract. 2007 Jul;19(7):368-77.PMID: 17680902 [PubMed - indexed for MEDLINE]Related articles

    19.

    The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes: a randomized trial.

    Zinman B, Hoogwerf BJ, Durán García S, Milton DR, Giaconia JM, Kim DD, Trautmann ME, Brodows RG.

    Ann Intern Med. 2007 Apr 3;146(7):477-85. Erratum in: Ann Intern Med. 2007 Jun 19;146(12):896. PMID: 17404349 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    The effect of metformin on blood glucose control in overweight patients with Type 1 diabetes.

    Khan AS, McLoughney CR, Ahmed AB.

    Diabet Med. 2006 Oct;23(10):1079-84.PMID: 16978371 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity